Jennifer Taubert
Courtesy of Johnson & Johnson
- Company/AffiliationJohnson & Johnson
- TitleEVP and Worldwide Chairman, Innovative Medicine
Jennifer Taubert sits at the helm of Johnson & Johnson’s $54 billion pharmaceuticals division. Between 2023 and 2024, J&J Innovative Medicine completed 24 business development transactions, deploying more than $5 billion through acquisitions and licensing deals. Taubert has been named to the Fortune Most Powerful Women list for eight consecutive years and serves on McDonald’s board of directors.